Inozyme Pharma Inc (INZY)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -31.987 | -43.119 | -51.93 | -38.664 | -51.048 | -41.859 |
Return on Equity (%) | 100.382 | 83.764 | -90.362 | -42.356 | -58.913 | -54.984 |
Return on Invested Capital (%) | 166.698 | 87.949 | -104.699 | -45.706 | -61.351 | -50.16 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -1.636 | -3.69 | 6.761 | 4.617 | 2.931 | 2.275 |
Earnings Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
Cash Per Share | 4.24 | 3.511 | 1.199 | 0.985 | 0.815 | 0.56 |
Working Capital Per Share | 4.819 | 4.913 | 6.03 | 4.382 | 2.888 | 2.94 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
EBITDA Per Share | -0.821 | -2.191 | -2.413 | -2.392 | -1.66 | -1.152 |
Free Cash Flow Per Share | -0.794 | -2.185 | -2.398 | -2.404 | -1.668 | -1.161 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 8,48M | 9M | 23,39M | 23,67M | 40,39M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 40,39M | 40,39M | 43,77M | 46,38M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 192,08M |
Ratio cours/bénéfice | -2,56 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 5,27 |
Ratio prix/valeur comptable | 1,3 |
Rendement de dividende | - |
Actions en circulation | 64,24M |
Volume moyen (1 semaine) | 627,26k |
Volume moyen (1 mois) | 946,9k |
Variation sur 52 semaines | -35,65% |
Plus haut sur 52 semaines | 7,795 |
Plus bas sur 52 semaines | 2,385 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales